Breaking News
Get 45% Off 0
Is it finally time to sell Nvidia ahead of earnings?
Read More

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
LPL Financial Reports Improvement In November Activity By Zacks Investment Research - Dec 19, 2017

LPL Financial Holdings (NASDAQ:LPLA) registered total brokerage and advisory assets of $575 billion in November 2017, reflecting an increase of 1.5% from the previous month. Of these, brokerage...

Zacks Investment Research
Should Value Investors Consider EZCORP (EZPW) Stock? By Zacks Investment Research - Dec 19, 2017

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...

Zacks Investment Research
Are Macy's (M) Efforts Enough To Counter Retail Headwinds? By Zacks Investment Research - Dec 19, 2017

The retail landscape has been undergoing a fundamental change, with technology playing a major role and the focus shifting to online shopping. This transition in shopping pattern is compelling...

Zacks Investment Research
Is Enova International (ENVA) A Suitable Value Stock? By Zacks Investment Research - Dec 19, 2017

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...

Zacks Investment Research
Facebook (FB) Launches Tools To Prevent Misuse Of Platform By Zacks Investment Research - Dec 19, 2017

Facebook Inc. (NASDAQ:FB) announced a number of initiatives in its attempts to build a safer community.In its latest blog post, Facebook revealed that “engagement bait” posts that...

Zacks Investment Research
Can Wal-Mart Combat Amazon Post Whole Foods Buyout? By Zacks Investment Research - Dec 19, 2017

While the dotcom era was all about small exciting tech startups, 2017 was possibly the year when getting bigger became truly better. It was also a year when competitors decided that imitation was the...

Zacks Investment Research
New Strong Buy Stocks For December 20th By Zacks Investment Research - Dec 19, 2017

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:Stifel Financial Corp. (SF): This financial services and bank holding company has seen the Zacks Consensus Estimate for its current...

Zacks Investment Research
Will Southern's (SO) Vogtle Perish Post Dec 21 PSC Verdict? By Zacks Investment Research - Dec 19, 2017

Georgia Public Service Commission (PSC) will take a final call regarding The Southern Company’s (NYSE:SO) Vogtle project on Dec 21. Initially, the hearing was scheduled for February 2018 but...

Zacks Investment Research
New Brands To Boost Colgate's Personal Care Range In 2018 By Zacks Investment Research - Dec 19, 2017

Colgate-Palmolive Co. (NYSE:CL) has signed agreements to acquire two professional skin care brands, PCA Skin and EltaMD. The acquisitions are in sync with Colgate’s strategy to focus on...

Zacks Investment Research
IPO ETF (FPX) Hits New 52-Week High By Zacks Investment Research - Dec 19, 2017

For investors seeking momentum, First Trust US Equity Opportunities ETF (V:FPX) is probably on radar now. The fund just hit a 52-week high, and is up 26.7% from its 52-week low price of...

Zacks Investment Research
Honda (HMC) Set To Unveil New Gas-Electric Hybrid Sedan By Zacks Investment Research - Dec 19, 2017

Honda Motor Co., Ltd. (NYSE:HMC) is set to unveil a new five-passenger gas-electric hybrid sedan, Insight, at the Detroit auto show next month, per an AP report. The Japanese automaker is of the...

Zacks Investment Research
Philips Teams Up With HomeLab To Improve Indoor Air Quality By Zacks Investment Research - Dec 19, 2017

Koninklijke Philips N.V. (NYSE:PHG) recently announced that it has partnered with HomeLab to create a healthy home environment. The partnership will leverage Philips Air Purifier tool along with...

Zacks Investment Research
Exelixis' Cabometyx Gets FDA Nod For First-Line Kidney Cancer By Zacks Investment Research - Dec 19, 2017

Exelixis, Inc. (NASDAQ:EXEL) recently announced FDA approval for label expansion of its lead drug Cabometyx for the treatment of previously untreated advanced renal cell carcinoma (RCC).The approval...

Zacks Investment Research
PerkinElmer (PKI) Closes EUROIMMUN Acquisition For $1.3B By Zacks Investment Research - Dec 19, 2017

PerkinElmer, Inc. (NYSE:PKI) recently announced the completion of the buyout of EUROIMMUN Medical Laboratory Diagnostics AG for approximately $1.3 billion in cash. The latter is an autoimmune...

Continue with Apple
Continue with Google
or
Sign up with Email